Quality Assurance from Rivarp
To complement its pursuit for quality and innovation, the quality system of M/s. Rivarp Medical Private Limited was accredited by the BSI in EU (ISO13485：2003), and passed inspection of Good Manufacturing Practice for Medical Devices.
Rivarp Medical’s Manufacturing facility is approved for Class-I, II, III and class IV medical devices by the licensing authority Central Drug Standard Control Organization (CDSCO).
Business Segment
Spine Implants | Cardiology Devices | Cardiology Accessories | Critical Care Products
Product Quality & Safety
Provide the product which is economical & of high quality – It is the promise we make to our customer – “Quality Matters “
Quality Management System
Our Quality management system that complies with the requirements of current versions of ISO 13485: 2016 & 9001 : 2015 and passed inspection of Good Manufacturing practise for Medical Devices
Rivarp Medical’s Manufacturing facility is approved for Class A,B,C and Class D medical devices by licensing authority Central Drug Standard Control Organization ( CDSCO )
Quality Control
Rivarp’s Post market surveillance process evaluates data from different hospitals. The clinical evaluation reporting process for collecting, analysing and accessing clinical data , it is done in order to verify the safety performance and benefits of our medical devices. If our post market surveillance process identifies a risk, Rivarp follows a field action process that determines if a recall action needs to be taken.
Product Testing
Rivarp Medical ‘s product undergoes suitable level of testing prior to the dispatch of end product from the factory.
Throughout the design and manufacturing process our products are tested for usability, Performance and safety. All procedures to control minor, moderate and major design changes are established and documented.
Supply Chain Quality & Safety
We monitor our approved distributors for quality performance by routinely auditing and monitoring delivery performance data.
Rivarp Medical Private Limited was incorporated with an objective identifying and developing technologies and therapeutic areas which will help the physicians in enhancing their clinical outcomes keeping the patient’s affordability in mind. For the last few decades, most of the newer technologies in medical science, particularly in interventional cardiology and implantable medical devices in general, were launched by US/EU multinationals as they had the expertise and the financial capabilities which are key to create such radical innovations. Most of these technologies have improved the treatment and clinical outcomes in many therapeutic areas and have been very successful. However, there have been inherent limitations in terms of their affordability in developing countries like India, where the insurance and state-run reimbursement schemes only cover a small portion of the population and most of the patients must fund their treatment from their own earnings.
At Rivarp, our core philosophy is ‘care for human health’, which is the cornerstone of comfort and happiness. We are committed to improving the health of people by advancing science and continuously providing safe, effective and more economical medical solutions to healthcare professionals we are collaborating with. We are constantly developing a great diversity of meaningful innovation for the people we serve and care. We keep pursuing the best quality and increasing efficiency for better lives.